Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:50 PM
Ignite Modification Date:
2025-12-24 @ 10:50 PM
NCT ID:
NCT04530669
Eligibility Criteria:
Inclusion Criteria:
\- Both genders
* Age from 18-50 years
* All MS types will be included (relapsing remitting "RR", secondary progressive "SP, and primary progressive "PP")
* Patients with residual motor / cerebellar / sphincteric impairment that are not responding to conventional pharmacological treatments.
* At least 6 months after the last relapse.
* EDSS from 2-6.5.
* All patients should be receiving a disease modifying therapy with stabilization of the disease course for 1 year in case of SPMS and PPMS.
* Patients that can pay regular visits to the physical center without potential interruption.
* Patients who agree to participate and sign the informed consent. - body mass index (20:29) kg/m2
Exclusion Criteria:
* cognitive impairment that can hinder the ability to communicate or to understand program instructions.
* neurological deficits due to any disease other than MS
* orthopedic abnormalities,
* secondary musculoskeletal complication.
* Patients who refuse participation or signing the informed consent.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
50 Years
Study:
NCT04530669
Study Brief:
Protocol Section:
NCT04530669